This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135:41-50.GuptaKHootonTMStammWEIncreasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infectionsAnn Intern Med200113541–5010.7326/0003-4819-135-1-200107030-00012Search in Google Scholar
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103-20. 10.1093/cid/ciq257GuptaKHootonTMNaberKGWulltBColganRMillerLGet alInternational clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClin Infect Dis201152e103–2010.1093/cid/ciq257Open DOISearch in Google Scholar
Naber KG, Funfstuck R, Wagenlehner FME. Aktuelle Empfehlungen zur Antibiotikatherapie von Harnwegsinfektionen. Urologie Scan. 2015;2:57-78. doi 10.1055/s-0034-1391490.NaberKGFunfstuckRWagenlehnerFMEAktuelle Empfehlungen zur Antibiotikatherapie von HarnwegsinfektionenUrologie Scan2015257–7810.1055/s-0034-1391490Open DOISearch in Google Scholar
Jovanović A, Stevanović R, Pristaš I, Stanić A, Petrovčić M, Benković V, et al. Učestalost, dijagnostika i liječenje infekcija mokraćnog sustava u ordinacijama obiteljske medicine. Medicus. 2006;15:339-44.JovanovićAStevanovićRPristašIStanićAPetrovčićMBenkovićVet alUčestalost, dijagnostika i liječenje infekcija mokraćnog sustava u ordinacijama obiteljske medicineMedicus200615339–44Search in Google Scholar
Croatian Institute for Public Health. Croatian Health Statistics Yearbook 2014. Accessed April 15th, 2017 at: http://www.hzjz.hr/wp-content/uploads/2015/05/ljetopis_2014.pdfCroatian Institute for Public HealthCroatian Health Statistics Yearbook 2014. Accessed April 15th2017http://www.hzjz.hr/wp-content/uploads/2015/05/ljetopis_2014.pdfSearch in Google Scholar
Škerk V, Tambić Andrašević A, Andrašević S, Sušić E, Mlinarić Džepina A, Mađarić V, et al. Smjernice antimikrobnog liječenja i profilakse infekcija mokraćnog sustava. Accessed April 15th, 2017 at: http://iskra.bfm.hr/hrv/guidlinesarticle.aspx?id=62ŠkerkVTambić AndraševićAAndraševićSSušićEMlinarić DžepinaAMađarićVet alSmjernice antimikrobnog liječenja i profilakse infekcija mokraćnog sustava. Accessed April 15th2017http://iskra.bfm.hr/hrv/guidlinesarticle.aspx?id=62Search in Google Scholar
Škerk V, Tambić Andrašević A, Sušić E. Dopune i promjene ISKRA hrvatskih nacionalnih smjernica za liječenje i profilaksu infekcija mokraćnog sustava u odraslih. Infektol Glasnik. 2014;34:177-81.ŠkerkVTambić AndraševićASušićEDopune i promjene ISKRA hrvatskih nacionalnih smjernica za liječenje i profilaksu infekcija mokraćnog sustava u odraslihInfektol Glasnik201434177–81Search in Google Scholar
Croatian Institute for Health Insurance. Osnovna lista lijekova HZZO – u primjeni od 18.02.2016. Accessed March 10th, 2017 at: http://www.hzzo.hr/zdravstveni-sustav-rh/trazilica-za-lijekove-s-vazecih-lista/Croatian Institute for Health InsuranceOsnovna lista lijekova HZZO – u primjeni od 18.02.2016. Accessed March 10th2017http://www.hzzo.hr/zdravstveni-sustav-rh/trazilica-za-lijekove-s-vazecih-lista/Search in Google Scholar
Desgrandchamps D. Increasing rate of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens. Antimicrob Agents Chemother. 1989;33:595-96.DesgrandchampsDIncreasing rate of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimensAntimicrob Agents Chemother198933595–9610.1128/AAC.33.4.595-bSearch in Google Scholar
Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother. 1988;32:1285-88.KreskenMWiedemannBDevelopment of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinAntimicrob Agents Chemother1988321285–8810.1128/AAC.32.8.1285Search in Google Scholar
European Antimicrobial Resistance Surveillance Network (EARS-Net). Accessed March 15th, 2017 at: http://ecdc.europa.eu/en/activities/diseaseprogrammes/ARHAI/Pages/surveillance_networks.aspx#sthash.P8Th57h6.dpufEuropean Antimicrobial Resistance Surveillance Network (EARS-Net)Accessed March 15th2017http://ecdc.europa.eu/en/activities/diseaseprogrammes/ARHAI/Pages/surveillance_networks.aspx#sthash.P8Th57h6.dpufSearch in Google Scholar
Tambić Andrašević A, Tambić T, Katalinić Janković V, Payerl Pal M, Bukovski S, Butić I, et al. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2014. godini. Zagreb: Akademija medicinskih znanosti Hrvatske, 2015. Accessed April 22nd, 2017 at: http://www.iskra.bfm.hr/hrv/Resistance.aspx?id=66Tambić AndraševićATambićTKatalinić JankovićVPayerl PalMBukovskiSButićIet alOsjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2014. godini. Zagreb: Akademija medicinskih znanosti Hrvatske, 2015. Accessed April 22nd2017http://www.iskra.bfm.hr/hrv/Resistance.aspx?id=66Search in Google Scholar
Tambić Andrašević A, Tambić T, Katalinić Janković V, Payerl Pal M, Bukovski S, Butić I, et al. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2013. godini. Zagreb: Akademija medicinskih znanosti Hrvatske, 2014. Accessed April 22nd, 2017 at: http://www.iskra.bfm.hr/hrv/Resistance.aspx?id=66Tambić AndraševićATambićTKatalinić JankovićVPayerl PalMBukovskiSButićIet alOsjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2013. godini. Zagreb: Akademija medicinskih znanosti Hrvatske, 2014. Accessed April 22nd2017http://www.iskra.bfm.hr/hrv/Resistance.aspx?id=66Search in Google Scholar
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother. 2011;66(Suppl 6):vi3-12. 10.1093/jac/dkr453AdriaenssensNCoenenSVersportenAMullerAMinaluGFaesCet alEuropean Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009)J Antimicrob Chemother201166(Suppl 6)vi3–1210.1093/jac/dkr453Open DOISearch in Google Scholar
Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87. 10.1016/S0140-6736(05)17907-0GoossensHFerechMVanderStichele RElseviersMOutpatient antibiotic use in Europe and association with resistance: a cross-national database studyLancet2005365579–8710.1016/S0140-6736(05)17907-0Open DOISearch in Google Scholar
Aarason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Brit Med J. 1996;313:387.AarasonVAKristinssonKGSigurdssonJAStefansdottirGMolstadSGudmundssonSDo antimicrobials increase the carriage rate of penicillin resistant pneumococci in children?Cross sectional prevalence study Brit Med J199631338710.1136/bmj.313.7054.38723517978761224Search in Google Scholar
European antimicrobial consumption surveillance. Accessed March 31th, 2017 at: https://ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/report-protocolEuropean antimicrobial consumption surveillanceAccessed March 31th2017https://ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/report-protocolSearch in Google Scholar
Naber KG. Neue Aspekte zur Diagnose und Therapie der unkomplizierten Zystitis. Urologe. 2014;53:1489-94.NaberKGNeue Aspekte zur Diagnose und Therapie der unkomplizierten ZystitisUrologe2014531489–9410.1007/s00120-014-3564-725252819Search in Google Scholar
Wagenlehner FME, Schmiemann G, Hoyme U et al. Epidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulanterworbener Harnwegsinfektionen bei erwachsenen Patienten (Langfassung). S-3 Leitlinie AWMF-Register-Nr. 043/044 Harnwegsinfektionen, 2010. Accessed April 8th, 2017 at: http://www.awmf.orgWagenlehner FME, Schmiemann G, Hoyme U et alEpidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulanterworbener Harnwegsinfektionen bei erwachsenen Patienten (Langfassung). S-3 Leitlinie AWMF-Register-Nr. 043/044 Harnwegsinfektionen, 2010. Accessed April 8th2017http://www.awmf.orgSearch in Google Scholar
Croatian agency for medicines (HALMED). Izviješće o potrošnji lijekova u Republici Hrvatskoj u 2014. godini. Accessed April 8th, 2017 at: http://www.halmed.hr/Novosti-i-edukacije/Publikacije-i-izvjesca/Izvjesca-o-potrosnji-lijekova/Izvjesce-o-prometu-lijekova-u-Republici-Hrvatskoj-u-2014/#Tablica_1Croatian agency for medicines (HALMED)Izviješće o potrošnji lijekova u Republici Hrvatskoj u 2014. godini. Accessed April 8th2017http://www.halmed.hr/Novosti-i-edukacije/Publikacije-i-izvjesca/Izvjesca-o-potrosnji-lijekova/Izvjesce-o-prometu-lijekova-u-Republici-Hrvatskoj-u-2014/#Tablica_1Search in Google Scholar
Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, et al. Uropathogens and host characteristics. J Clin Microbiol. 2008;46:3980-6.TabibianJHGornbeinJHeidariADienSLLauVHChahalPet alUropathogens and host characteristicsJ Clin Microbiol2008463980–610.1128/JCM.00339-08259326518842936Search in Google Scholar
Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, et al. The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens. 2016;5:10.WagenlehnerFTandogduZBartolettiRCaiTCekMKulchavenyaEet alThe global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infectionsPathogens201651010.3390/pathogens5010010Search in Google Scholar
McQuiston Haslund J, Rosborg Dinesen M, Sternhagen Nielsen AB, Llor C, Bjerrum L. Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe. Scand J Prim Health Care. 2013;31:235-40. 10.3109/02813432.2013.844410McQuistonHaslund JRosborgDinesen MSternhagenNielsen ABLlorCBjerrumLDifferent recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in EuropeScand J Prim Health Care201331235–4010.3109/02813432.2013.844410Open DOISearch in Google Scholar
Grabe M, Bjerklund-Johansen TE, Bartoletti R, Tai C, Cek M, Koves B, et al. Guidelines on urological infections. Arnhem: European Association of Urology, 2014: Part 19:1-107. Accessed February 25th, 2017 at: http://www.uroweb.org/gls/pdf/19%20Urological%20infections_LR.pdfGrabeMBjerklund-JohansenTEBartolettiRTaiCCekMKovesBet alGuidelines on urological infections. Arnhem: European Association of Urology, 2014: Part 19:1-107Accessed February 25th2017http://www.uroweb.org/gls/pdf/19%20Urological%20infections_LR.pdfSearch in Google Scholar
Cunha BA. New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. Med Clin N Am. 2006;90: 1089-107. 10.1016/j.mcna.2006.07.006CunhaBANew uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisitedMed Clin N Am200690 1089–10710.1016/j.mcna.2006.07.006Open DOISearch in Google Scholar
Cunha BA. Empiric therapy of genitourinary tract infections. In: Antibiotic essentials. Burlington: Jones and Bartlett Learning, 2012:103.CunhaBAEmpiric therapy of genitourinary tract infectionsAntibiotic essentialsBurlingtonJones and Bartlett Learning2012103Search in Google Scholar
Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs. 2001;61:353-64.GuayDRAn update on the role of nitrofurans in the management of urinary tract infectionsDrugs200161353–6410.2165/00003495-200161030-00004Search in Google Scholar
McOsker CC, Fitzpatrick PM. Nitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infections. J Antimicrob Chemother. 1994;33:23-30.McOskerCCFitzpatrickPMNitrofurantoin: preferred empiric therapy for community-acquired lower urinary tract infectionsJ Antimicrob Chemother19943323–3010.1093/jac/33.suppl_A.23Search in Google Scholar
Vlahović Palčevski V, Abram M (editors). Smjernice za propisivanje antimikrobnih lijekova u primarnoj zdravstvenoj zaštiti 2014./2015. 2nd ed. Rijeka: Medicinski fakultet, 2015:38-40.VlahovićPalčevski VAbramM (editors)Smjernice za propisivanje antimikrobnih lijekova u primarnoj zdravstvenoj zaštiti 2014./20152nd edRijekaMedicinski fakultet201538–40Search in Google Scholar
ESAC-Net. Distribution of antimicrobial consumption by antimicrobial group. Accessed March 3rd, 2018 at: https://ecdc.europa.eu/en/antimicrobial-consumption/database/distribution-by-antimicrobial-groupESAC-NetDistribution of antimicrobial consumption by antimicrobial group. Accessed March 3rd2018https://ecdc.europa.eu/en/antimicrobial-consumption/database/distribution-by-antimicrobial-groupSearch in Google Scholar
WHO Collaborating Centre for Drug Statistics Methodology. Antiinfectives for systemic use. Accessed March 2nd, 2018 at: https://www.whocc.no/atc_ddd_index/?code=J01&showdescription=noWHO Collaborating Centre for Drug Statistics MethodologyAntiinfectives for systemic use. Accessed March 2nd2018https://www.whocc.no/atc_ddd_index/?code=J01&showdescription=noSearch in Google Scholar
Norfloxacin. Martindale. The complete drug reference (Sweetman SC ed.), Pharmaceutical Press. 36th ed. 2009:309.Norfloxacin. Martindale. The complete drug reference (Sweetman SC ed.)Pharmaceutical Press36th ed2009309Search in Google Scholar
Metz-Gercek S, Maieron A, Strauß R, Wieninger P, ApfalterP, Mittermayer H. Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis. 2009;9:61 10.1186/1471-2334-9-61Metz-GercekSMaieronAStraußRWieningerPApfalterPMittermayerHTen years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in AustriaBMC Infect Dis200996110.1186/1471-2334-9-61Open DOISearch in Google Scholar
Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, et al. A cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. 2014;14:381-7. 10.1016/S1473-3099(14)70071-4VersportenABolokhovetsGGhazaryanLAbilovaVPyshnikGSpasojevicTet alA cross-national database study in coordination with the WHO Regional Office for EuropeLancet Infect Dis201414381–710.1016/S1473-3099(14)70071-4Open DOISearch in Google Scholar
Glinz D, Leon Reyes S, Saccilotto R, Widmer AF, Zeller A, Bucher HC, et al. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. J Antimicrob Chemother. 2017;72: 3205-12. 10.1093/jac/dkx278GlinzDLeonReyes SSaccilottoRWidmerAFZellerABucherHCet alQuality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide surveyJ Antimicrob Chemother201772 3205–1210.1093/jac/dkx27828961815Open DOISearch in Google Scholar
Titelman E, Iversen A, Kahlmeter G, Giske CG. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae. APMIS. 2011;119:853-63.TitelmanEIversenAKahlmeterGGiskeCGAntimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniaeAPMIS2011119853–6310.1111/j.1600-0463.2011.02766.x22085361Search in Google Scholar
Dalhoff A. Resistance surveillance studies: a multifaceted problem - the fluoroquinolone example. Infection. 2012;40:239-62. 10.1007/s15010-012-0257-2DalhoffAResistance surveillance studies: a multifaceted problem - the fluoroquinolone exampleInfection201240239–6210.1007/s15010-012-0257-222460782Open DOISearch in Google Scholar
Mahesh E, Medha Y, Indumathi VA, Kumar PS, Khan MW, Punith K. Community-acquired urinary tract infection in the elderly. Br J Med Pract. 2011;4:a406.MaheshEMedhaYIndumathiVAKumarPSKhanMWPunithKCommunity-acquired urinary tract infection in the elderlyBr J Med Pract20114a406Search in Google Scholar
Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by extended spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42:1089-94.Rodriguez-BanoJNavarroMDRomeroLMartinez-MartinezLMuniainMAPereaEJet alEpidemiology and clinical features of infections caused by extended spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patientsJ Clin Microbiol2004421089–9410.1128/JCM.42.3.1089-1094.200435684315004058Search in Google Scholar
Davis A, Obi B, Ingram M. Investigating urinary tract infections in children. BMJ. 2013;346:e8654. 10.1136/bmj.e8654DavisAObiBIngramMInvestigating urinary tract infections in childrenBMJ2013346e865410.1136/bmj.e865423364051Open DOISearch in Google Scholar
Urifos (fosfomicin): summary of product characteristics. HALMED, 2016. Accessed Marh 3rd, 2018 at: http://www.halmed.hr/Lijekovi/Baza-lijekova/Urifos-2-g-granule-za-oralnu-otopinu/12619/Urifos (fosfomicin): summary of product characteristicsHALMED, 2016. Accessed Marh 3rd2018http://www.halmed.hr/Lijekovi/Baza-lijekova/Urifos-2-g-granule-za-oralnu-otopinu/12619/Search in Google Scholar
Milošević D, Batinić D, Trkulja V, Tambić Andrašević A, Filipović Grčić B, Vrljičak K, et al. Rational therapy of urinary tract infections in children in Croatia. Acta Clin Croat. 2016;55:428-39. 10.20471/acc.2016.55.03.12MiloševićDBatinićDTrkuljaVTambićAndrašević AFilipovićGrčić BVrljičakKet alRational therapy of urinary tract infections in children in CroatiaActa Clin Croat201655428–3910.20471/acc.2016.55.03.1229045108Open DOISearch in Google Scholar
Scottish Intercollegiate Guidelines Network. Management of suspected bacterial urinary tract infections in adults: a national clinical guideline. SIGN July 2012. Accessed February 2nd, 2017 at: http://www.sign.ac.uk/guidelines/fulltext/88/Scottish Intercollegiate Guidelines NetworkManagement of suspected bacterial urinary tract infections in adults: a national clinical guideline. SIGN July 2012. Accessed February 2nd2017http://www.sign.ac.uk/guidelines/fulltext/88/Search in Google Scholar
Baerheim A. Empyrical treatment uncomplicated cystitis: keep it simple. BMJ. 2001;323:1197-8.BaerheimAEmpyrical treatment uncomplicated cystitis: keep it simpleBMJ20013231197–810.1136/bmj.323.7323.1197112168011719397Search in Google Scholar
